Steward Partners Investment Advisory’s Transmedics TMDX Stock Holding History

Steward Partners Investment Advisory’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.58K	Hold	26	–	–	﹤0.01%	3977
2025 Q4	$3.16K	Sell	26 -8	-24%	-$1K	﹤0.01%	3833
2025 Q3	$3.81K	Buy	34 +23	+209%	+$2.69K	﹤0.01%	3736
2025 Q2	$1.47K	Sell	11 -97	-90%	-$10.7K	﹤0.01%	3801
2025 Q1	$7.27K	Buy	108 +56	+108%	+$3.85K	﹤0.01%	3246
2024 Q4	$3.24K	Buy	52 +44	+550%	+$4.1K	﹤0.01%	3497
2024 Q3	$1.26K	Sell	8 -49	-86%	-$7.55K	﹤0.01%	3505
2024 Q2	$8.59K	Hold	57	–	–	﹤0.01%	2870
2024 Q1	$4.21K	Buy	+57	New	+$4.7K	﹤0.01%	3092
2021 Q3	–	Sell	-8,400	Closed	-$279K	–	3330
2021 Q2	$279K	Sell	8,400 -1,000	-11%	-$27.7K	﹤0.01%	1236
2021 Q1	$390K	Buy	+9,400	New	+$289K	0.01%	983

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's TMDX Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Transmedics (TMDX) position steady in Q1 2026 at 26 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #3977.

Steward Partners Investment Advisory first reported a position in TMDX in Q1 2021 and has held it in 11 quarters since. The position peaked at $390K in Q1 2021. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Steward Partners Investment Advisory held 26 shares of Transmedics worth $2.58K as of Q1 2026.
Steward Partners Investment Advisory left its Transmedics share count unchanged in Q1 2026.
Transmedics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3977 holding.
Steward Partners Investment Advisory first reported a position in Transmedics in Q1 2021 and has held it in 11 quarters since.
Steward Partners Investment Advisory's Transmedics position peaked at $390K in Q1 2021.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.